Camber Capital Management LP Myriad Genetics Inc Transaction History
Camber Capital Management LP
- $4.08 Billion
- Q1 2024
A detailed history of Camber Capital Management LP transactions in Myriad Genetics Inc stock. As of the latest transaction made, Camber Capital Management LP holds 7,635,000 shares of MYGN stock, worth $187 Million. This represents 3.99% of its overall portfolio holdings.
Number of Shares
7,635,000
Previous 7,635,000
-0.0%
Holding current value
$187 Million
Previous $146 Million
11.39%
% of portfolio
3.99%
Previous 3.72%
Shares
14 transactions
Others Institutions Holding MYGN
# of Institutions
191Shares Held
94.2MCall Options Held
280KPut Options Held
14.3K-
Black Rock Inc. New York, NY14.9MShares$364 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$245 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.06MShares$197 Million0.03% of portfolio
-
State Street Corp Boston, MA5.4MShares$132 Million0.01% of portfolio
-
Glenview Capital Management, LLC New York, NY4.94MShares$121 Million1.85% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.97B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...